Research News for October 2006
11–11 of 11 articles
-
Femara Reduces Recurrence Risk
Hormonal therapy has been shown to be very effective in reducing the risk of hormone-receptor-positive, early-stage breast cancer coming back (recurring) in postmenopausal women. To reduce the risk of ...
11–11 of 11 articles
